For this, PBL from COVID-19 seropositive donors were stimulated with a SARS-CoV-2-derived peptide pool for 6 days and subsequently selected based on the expression of the cellular activation markers CD71 and CD98 (Figure 2A) [38]. Here, TFRC is linked to COVID-19.